ArticleBMJ (Clinical research ed.)2025

Sodium-glucose cotransporter-2 inhibitors and risk of autoimmune rheumatic diseases: population based cohort study.

Bin Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.